Factors associated with the clinical response to nonsurgical periodontal therapy in people with type 2 diabetes mellitus

Bryan S. Michalowicz, Leslie Hyman, Wei Hou, Thomas W. Oates, Michael Reddy, David W. Paquette, James A. Katancik, Steven P. Engebretson

Research output: Research - peer-reviewArticle

  • 9 Citations

Abstract

Background. Type 2 diabetes mellitus (T2DM) is a growing health problem worldwide. People with T2DM are at risk of experiencing periodontitis and likely require treatment. Using data from the national multicenter Diabetes and Periodontal Therapy Trial (DPTT), the authors assessed patient-based characteristics associated with the clinical response to nonsurgical therapy.

Methods. The DPTT investigators randomly assigned adults with T2DM (hemoglobin A1c (HbA1c) ≥ 7 percent and <9 percent) and moderate to advanced periodontitis to receive immediate or delayed therapy (scaling and root planing, oral hygiene instruction, chlorhexidine rinse). The investigators assessed probing depth (PD), clinical attachment level (CAL), bleeding on probing (BOP), and medical conditions at baseline, three months and six months. Six-month changes in mean PD, CAL and BOP defined the treatment response. Complete data were available for 473 of 514 DPTT participants. The authors used multiple regression models to evaluate participantlevel factors associated with the response. Results. More severe baseline PD, CAL and BOP were associated with greater improvements in these same measurements (P <.0001). Hispanic participants experienced greater improvements in PD and CAL than did non-Hispanic participants (P <.0001). Obese participants (those with a body mass index > 30 kilograms per square meter) experienced greater reductions in PD and BOP than did participants who were not obese (P <.001). Age, sex, HbA1c values, diabetes duration, and smoking were not associated with change in any outcome (P > .1). Conclusions. In patients with T2DM, baseline disease severity was associated with the clinical response to nonsurgical periodontal therapy. Body mass index and Hispanic ethnicity-but not glycemic control, diabetes duration or smoking-also may be useful in predicting clinical changes in this population. Practical Implications. These findings could help clinicians identify patients with T2DM who may or may not respond well to initial periodontal treatment.

LanguageEnglish (US)
Pages1227-1239
Number of pages13
JournalJournal of the American Dental Association
Volume145
Issue number12
DOIs
StatePublished - Dec 1 2014
Externally publishedYes

Fingerprint

Type 2 Diabetes Mellitus
Therapeutics
Hemorrhage
Periodontitis
Hispanic Americans
Body Mass Index
Smoking
Research Personnel
Root Planing
Hemoglobin A
Chlorhexidine
Oral Hygiene
Population
Global Health

Keywords

  • Diabetes mellitus
  • Periodontitis
  • Treatment

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Michalowicz, B. S., Hyman, L., Hou, W., Oates, T. W., Reddy, M., Paquette, D. W., ... Engebretson, S. P. (2014). Factors associated with the clinical response to nonsurgical periodontal therapy in people with type 2 diabetes mellitus. Journal of the American Dental Association, 145(12), 1227-1239. DOI: 10.14219/jada.2014.92

Factors associated with the clinical response to nonsurgical periodontal therapy in people with type 2 diabetes mellitus. / Michalowicz, Bryan S.; Hyman, Leslie; Hou, Wei; Oates, Thomas W.; Reddy, Michael; Paquette, David W.; Katancik, James A.; Engebretson, Steven P.

In: Journal of the American Dental Association, Vol. 145, No. 12, 01.12.2014, p. 1227-1239.

Research output: Research - peer-reviewArticle

Michalowicz, BS, Hyman, L, Hou, W, Oates, TW, Reddy, M, Paquette, DW, Katancik, JA & Engebretson, SP 2014, 'Factors associated with the clinical response to nonsurgical periodontal therapy in people with type 2 diabetes mellitus' Journal of the American Dental Association, vol 145, no. 12, pp. 1227-1239. DOI: 10.14219/jada.2014.92
Michalowicz BS, Hyman L, Hou W, Oates TW, Reddy M, Paquette DW et al. Factors associated with the clinical response to nonsurgical periodontal therapy in people with type 2 diabetes mellitus. Journal of the American Dental Association. 2014 Dec 1;145(12):1227-1239. Available from, DOI: 10.14219/jada.2014.92
Michalowicz, Bryan S. ; Hyman, Leslie ; Hou, Wei ; Oates, Thomas W. ; Reddy, Michael ; Paquette, David W. ; Katancik, James A. ; Engebretson, Steven P./ Factors associated with the clinical response to nonsurgical periodontal therapy in people with type 2 diabetes mellitus. In: Journal of the American Dental Association. 2014 ; Vol. 145, No. 12. pp. 1227-1239
@article{42918720e50741bb93b7951329191fb2,
title = "Factors associated with the clinical response to nonsurgical periodontal therapy in people with type 2 diabetes mellitus",
abstract = "Background. Type 2 diabetes mellitus (T2DM) is a growing health problem worldwide. People with T2DM are at risk of experiencing periodontitis and likely require treatment. Using data from the national multicenter Diabetes and Periodontal Therapy Trial (DPTT), the authors assessed patient-based characteristics associated with the clinical response to nonsurgical therapy.Methods. The DPTT investigators randomly assigned adults with T2DM (hemoglobin A1c (HbA1c) ≥ 7 percent and <9 percent) and moderate to advanced periodontitis to receive immediate or delayed therapy (scaling and root planing, oral hygiene instruction, chlorhexidine rinse). The investigators assessed probing depth (PD), clinical attachment level (CAL), bleeding on probing (BOP), and medical conditions at baseline, three months and six months. Six-month changes in mean PD, CAL and BOP defined the treatment response. Complete data were available for 473 of 514 DPTT participants. The authors used multiple regression models to evaluate participantlevel factors associated with the response. Results. More severe baseline PD, CAL and BOP were associated with greater improvements in these same measurements (P <.0001). Hispanic participants experienced greater improvements in PD and CAL than did non-Hispanic participants (P <.0001). Obese participants (those with a body mass index > 30 kilograms per square meter) experienced greater reductions in PD and BOP than did participants who were not obese (P <.001). Age, sex, HbA1c values, diabetes duration, and smoking were not associated with change in any outcome (P > .1). Conclusions. In patients with T2DM, baseline disease severity was associated with the clinical response to nonsurgical periodontal therapy. Body mass index and Hispanic ethnicity-but not glycemic control, diabetes duration or smoking-also may be useful in predicting clinical changes in this population. Practical Implications. These findings could help clinicians identify patients with T2DM who may or may not respond well to initial periodontal treatment.",
keywords = "Diabetes mellitus, Periodontitis, Treatment",
author = "Michalowicz, {Bryan S.} and Leslie Hyman and Wei Hou and Oates, {Thomas W.} and Michael Reddy and Paquette, {David W.} and Katancik, {James A.} and Engebretson, {Steven P.}",
year = "2014",
month = "12",
doi = "10.14219/jada.2014.92",
volume = "145",
pages = "1227--1239",
journal = "Journal of the American Dental Association",
issn = "0002-8177",
publisher = "American Dental Association",
number = "12",

}

TY - JOUR

T1 - Factors associated with the clinical response to nonsurgical periodontal therapy in people with type 2 diabetes mellitus

AU - Michalowicz,Bryan S.

AU - Hyman,Leslie

AU - Hou,Wei

AU - Oates,Thomas W.

AU - Reddy,Michael

AU - Paquette,David W.

AU - Katancik,James A.

AU - Engebretson,Steven P.

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Background. Type 2 diabetes mellitus (T2DM) is a growing health problem worldwide. People with T2DM are at risk of experiencing periodontitis and likely require treatment. Using data from the national multicenter Diabetes and Periodontal Therapy Trial (DPTT), the authors assessed patient-based characteristics associated with the clinical response to nonsurgical therapy.Methods. The DPTT investigators randomly assigned adults with T2DM (hemoglobin A1c (HbA1c) ≥ 7 percent and <9 percent) and moderate to advanced periodontitis to receive immediate or delayed therapy (scaling and root planing, oral hygiene instruction, chlorhexidine rinse). The investigators assessed probing depth (PD), clinical attachment level (CAL), bleeding on probing (BOP), and medical conditions at baseline, three months and six months. Six-month changes in mean PD, CAL and BOP defined the treatment response. Complete data were available for 473 of 514 DPTT participants. The authors used multiple regression models to evaluate participantlevel factors associated with the response. Results. More severe baseline PD, CAL and BOP were associated with greater improvements in these same measurements (P <.0001). Hispanic participants experienced greater improvements in PD and CAL than did non-Hispanic participants (P <.0001). Obese participants (those with a body mass index > 30 kilograms per square meter) experienced greater reductions in PD and BOP than did participants who were not obese (P <.001). Age, sex, HbA1c values, diabetes duration, and smoking were not associated with change in any outcome (P > .1). Conclusions. In patients with T2DM, baseline disease severity was associated with the clinical response to nonsurgical periodontal therapy. Body mass index and Hispanic ethnicity-but not glycemic control, diabetes duration or smoking-also may be useful in predicting clinical changes in this population. Practical Implications. These findings could help clinicians identify patients with T2DM who may or may not respond well to initial periodontal treatment.

AB - Background. Type 2 diabetes mellitus (T2DM) is a growing health problem worldwide. People with T2DM are at risk of experiencing periodontitis and likely require treatment. Using data from the national multicenter Diabetes and Periodontal Therapy Trial (DPTT), the authors assessed patient-based characteristics associated with the clinical response to nonsurgical therapy.Methods. The DPTT investigators randomly assigned adults with T2DM (hemoglobin A1c (HbA1c) ≥ 7 percent and <9 percent) and moderate to advanced periodontitis to receive immediate or delayed therapy (scaling and root planing, oral hygiene instruction, chlorhexidine rinse). The investigators assessed probing depth (PD), clinical attachment level (CAL), bleeding on probing (BOP), and medical conditions at baseline, three months and six months. Six-month changes in mean PD, CAL and BOP defined the treatment response. Complete data were available for 473 of 514 DPTT participants. The authors used multiple regression models to evaluate participantlevel factors associated with the response. Results. More severe baseline PD, CAL and BOP were associated with greater improvements in these same measurements (P <.0001). Hispanic participants experienced greater improvements in PD and CAL than did non-Hispanic participants (P <.0001). Obese participants (those with a body mass index > 30 kilograms per square meter) experienced greater reductions in PD and BOP than did participants who were not obese (P <.001). Age, sex, HbA1c values, diabetes duration, and smoking were not associated with change in any outcome (P > .1). Conclusions. In patients with T2DM, baseline disease severity was associated with the clinical response to nonsurgical periodontal therapy. Body mass index and Hispanic ethnicity-but not glycemic control, diabetes duration or smoking-also may be useful in predicting clinical changes in this population. Practical Implications. These findings could help clinicians identify patients with T2DM who may or may not respond well to initial periodontal treatment.

KW - Diabetes mellitus

KW - Periodontitis

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84913610633&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84913610633&partnerID=8YFLogxK

U2 - 10.14219/jada.2014.92

DO - 10.14219/jada.2014.92

M3 - Article

VL - 145

SP - 1227

EP - 1239

JO - Journal of the American Dental Association

T2 - Journal of the American Dental Association

JF - Journal of the American Dental Association

SN - 0002-8177

IS - 12

ER -